The Kynurenine Pathway in Gut Permeability and Inflammation
-
Published:2024-09-10
Issue:
Volume:
Page:
-
ISSN:0360-3997
-
Container-title:Inflammation
-
language:en
-
Short-container-title:Inflammation
Abstract
AbstractThe gut-brain axis (GBA) is a crucial communication network linking the gastrointestinal (GI) tract and the central nervous system (CNS). The gut microbiota significantly influences metabolic, immune, and neural functions by generating a diverse array of bioactive compounds that modulate brain function and maintain homeostasis. A pivotal mechanism in this communication is the kynurenine pathway, which metabolises tryptophan into various derivatives, including neuroactive and neurotoxic compounds. Alterations in gut microbiota composition can increase gut permeability, triggering inflammation and neuroinflammation, and contributing to neuropsychiatric disorders. This review elucidates the mechanisms by which changes in gut permeability may lead to systemic inflammation and neuroinflammation, with a focus on the kynurenine pathway. We explore how probiotics can modulate the kynurenine pathway and reduce neuroinflammation, highlighting their potential as therapeutic interventions for neuropsychiatric disorders. The review integrates experimental data, discusses the balance between neurotoxic and neuroprotective kynurenine metabolites, and examines the role of probiotics in regulating inflammation, cognitive development, and gut-brain axis functions. The insights provided aim to guide future research and therapeutic strategies for mitigating GI complaints and their neurological consequences.
Publisher
Springer Science and Business Media LLC
Reference126 articles.
1. Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., Wherry, E. J., & Artis, D. (2012). Commensal Bacteria Calibrate the Activation Threshold of Innate Antiviral Immunity. Immunity, 37(1). https://doi.org/10.1016/j.immuni.2012.04.011 2. Agnello, M., Carroll, L. N., Imam, N., Pino, R., Palmer, C., Varas, I., Greene, C., Hitschfeld, M., Gupta, S., Almonacid, D. E., & Hoaglin, M. C. (2020). Gut microbiome composition and risk factors in a large cross-sectional IBS cohort. BMJ Open Gastroenterology, 7(1). https://doi.org/10.1136/bmjgast-2019-000345 3. Allam-Ndoul, B., Castonguay-Paradis, S., & Veilleux, A. (2020). Gut microbiota and intestinal trans-epithelial permeability. In International Journal of Molecular Sciences (Vol. 21, Issue 17). https://doi.org/10.3390/ijms21176402 4. Anderson, E. W., Fishbein, J., Hong, J., Roeser, J., Furie, R. A., Aranow, C., Volpe, B. T., Diamond, B., & Mackay, M. (2021). Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus. Lupus Science and Medicine, 8(1). https://doi.org/10.1136/lupus-2021-000559 5. Appleton, J. (2018). The gut-brain axis: Influence of microbiota on mood and mental health. In Integrative Medicine (Boulder) (Vol. 17, Issue 4).
|
|